24 results
Hydroxychloroquine in COVID-19 - How might hydroxychloroquine help combat a COVID-19 infection?

It's important to remember that
Hydroxychloroquine in COVID ... help combat a COVID ... -19 infection? ... ATL MedStudent COVID ... #Coronavirus #Pharmacology
Drugs Used for the Treatment of COVID-19 Infection
LOPINAVIR / RITONAVIR
INTERFERON Beta-I
REMDESIVIR
HYDROXYCHLOROQUINE
TOCILIZUMAB

Piotr Okupski @PiotrOkupski - Original Infographic
the Treatment of COVID ... -19 Infection LOPINAVIR ... Medications #Treatment #COVID19 ... #Pharmacology # ... Table #Management
Cardiff COVID-19 Daily checklist - Matt Morgan
A daily checklist for critically ill #covid19 patients. Concentrates on
Norad > 0.5 mcg/kg ... Infection and drugs ... or other infections ... there a secondary infection ... criticalcare #SARSCoV2 #management
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... Tocilizumab 4-8mg/kg ... respiratory tract infection ... #Pharmacology # ... Management #Medications
Convalescent Plasma in COVID-19: Why It Might Work
Convalescent plasma (CP) as a passive antibody therapy has
Convalescent Plasma in COVID ... from a certain infection ... (e.g. ... patients fight the infection6 ... #coronavirus #management
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... /day or weekly injection ... (ER version) ... side effects (e.g ... Receptor #Agonists #Pharmacology
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
the Treatment of COVID ... -19 Infection ... Medications #Treatment #COVID19 ... #Pharmacology # ... Table #Management
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
define the type of infection ... prior resistance. e.g ... ampicillin #management ... #antibiogram #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... dose of 20–60 mg/kg ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... Treating Acute Infection ... amphotericin B, 3 to 5 mg/kg ... Prevention #Treatment #management ... #HIVAIDS #pharmacology